The Cardiolipin Antibody (ACL-IgM) test is a blood test used to detect the presence of IgM-type antibodies against cardiolipin, a phospholipid found in cell membranes. These antibodies are part of a group called antiphospholipid antibodies, which can increase the risk of abnormal blood clot formation. The test is primarily used to help diagnose antiphospholipid syndrome (APS), particularly in patients with a history of unexplained blood clots, recurrent miscarriages, or certain autoimmune disorders like systemic lupus erythematosus (SLE). Elevated ACL-IgM levels may indicate an increased risk for thrombosis or pregnancy complications. Results are interpreted along with other antibody tests, such as ACL-IgG and Lupus Anticoagulant, for a comprehensive assessment of clotting risk and autoimmune activity.

• Reports On : With 90 minute
• Sample Type : Blood
• Fasting : Not Required